Daniel A. Alexander
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Daniel A. Alexander has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
- Brian W. Pogue
Dartmouth College, Thayer School of Engineering, Hanover, New Hampshire, United States
11 shared publications - Petr Bruza
Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire
11 shared publications David J. Gladstone
Dartmouth College, Thayer School of Engineering, Hanover, New Hampshire, United States
5 shared publications- Rongxiao Zhang
University of Missouri
5 shared publications - Timothy C. Zhu
Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA
5 shared publications Brian W. Pogue
Univ. of Wisconsin, Madison (United States)
4 shared publications
Latest Publications
- 21 September 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (18) , 185001
Reproducibility of perfusion blood volume and ventilation imaging for lung function assessment
Objective. To assess the reproducibility of dual-energy CT (DECT) derived perfusion blood volume (PBV) and four-dimensional CT (4DCT) derived lung ventilation images. Approach. We enrolled patients on an IRB-approved clinical trial of functional lung imaging. All had locally advanced non-small cell lung cancer (NSCLC) treated with definitive, conventionally fractionated concurrent chemoradiation radiotherapy (RT) with or without consolidation immunotherapy. Patients completed imaging at three timepoints: (1) RT simulation, (2) second-week of RT, and (3) six-months post-RT. Free-breathing 4DCT and contrast-enhanced DECT were acquired at each timepoint. To evaluate reproducibility of PBV and ventilation maps, voxel intensities within the lung parenchyma from exclusively the first two timepoints were binned according to relative image intensity. Binary masks were generated at 20%, 40%, 60%, and 80% thresholds. Dice-similarity-coefficients (DSC) and structural-similarity-index-measure (SSIM) were calculated between the corresponding masks to assess the robustness and reproducibility. Scatter plots were generated to visualize voxel-wise intensity agreement. Main Results. Reproducibility of ventilation and perfusion images was evaluated in 28 patients between baseline and 2 week follow-up. For perfusion, the 20%–100% threshold showed the highest DSC (Scanner A = 0.91 ± 0.06; Scanner B = 0.81 ± 0.08), with progressive decreases at higher thresholds (Scanner A: 40%–100%(0.81 ± 0.08), 60%–100%(0.65 ± 0.07), and 80%–100%(0.48 ± 0.07); Scanner B: 40%–100%(0.73 ± 0.13), 60%–100%(0.58 ± 0.08), and 80%–100%(0.39 ± 0.07), respectively). Ventilation images showed a similar trend, with DSC of 20%–100%(0.83 ± 0.05), 40%–100%(0.71 ± 0.07), 60%–100%(0.59 ± 0.10), and 80%–100%(0.46 ± 0.11). For perfusion, mean SSIM for Scanner A decreased from 20%–100%(0.72 ± 0.10) to 80%–100%(0.66 ± 0.14); Scanner B from 20%–100%(0.55 ± 0.10) to 80%–100%(0.54 ± 0.08). For ventilation, the SSIM had a similar trend and declined from 20%–100%(0.73 ± 0.11) to 80%–100%(0.68 ± 0.15). Significance. DECT-derived perfusion showed superior reproducibility to 4DCT ventilation between timepoints 1 and 2, with consistently higher DSC and SSIM across thresholds. Despite systematic perfusion increases early in treatment, its spatial stability remained stronger, supporting DECT perfusion as a more robust biomarker for longitudinal lung function assessment and for informing adaptive, functionally-guided RT in NSCLC.
- 21 September 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (18) , 185001
Reproducibility of perfusion blood volume and ventilation imaging for lung function assessment
Objective. To assess the reproducibility of dual-energy CT (DECT) derived perfusion blood volume (PBV) and four-dimensional CT (4DCT) derived lung ventilation images. Approach. We enrolled patients on an IRB-approved clinical trial of functional lung imaging. All had locally advanced non-small cell lung cancer (NSCLC) treated with definitive, conventionally fractionated concurrent chemoradiation radiotherapy (RT) with or without consolidation immunotherapy. Patients completed imaging at three timepoints: (1) RT simulation, (2) second-week of RT, and (3) six-months post-RT. Free-breathing 4DCT and contrast-enhanced DECT were acquired at each timepoint. To evaluate reproducibility of PBV and ventilation maps, voxel intensities within the lung parenchyma from exclusively the first two timepoints were binned according to relative image intensity. Binary masks were generated at 20%, 40%, 60%, and 80% thresholds. Dice-similarity-coefficients (DSC) and structural-similarity-index-measure (SSIM) were calculated between the corresponding masks to assess the robustness and reproducibility. Scatter plots were generated to visualize voxel-wise intensity agreement. Main Results. Reproducibility of ventilation and perfusion images was evaluated in 28 patients between baseline and 2 week follow-up. For perfusion, the 20%–100% threshold showed the highest DSC (Scanner A = 0.91 ± 0.06; Scanner B = 0.81 ± 0.08), with progressive decreases at higher thresholds (Scanner A: 40%–100%(0.81 ± 0.08), 60%–100%(0.65 ± 0.07), and 80%–100%(0.48 ± 0.07); Scanner B: 40%–100%(0.73 ± 0.13), 60%–100%(0.58 ± 0.08), and 80%–100%(0.39 ± 0.07), respectively). Ventilation images showed a similar trend, with DSC of 20%–100%(0.83 ± 0.05), 40%–100%(0.71 ± 0.07), 60%–100%(0.59 ± 0.10), and 80%–100%(0.46 ± 0.11). For perfusion, mean SSIM for Scanner A decreased from 20%–100%(0.72 ± 0.10) to 80%–100%(0.66 ± 0.14); Scanner B from 20%–100%(0.55 ± 0.10) to 80%–100%(0.54 ± 0.08). For ventilation, the SSIM had a similar trend and declined from 20%–100%(0.73 ± 0.11) to 80%–100%(0.68 ± 0.15). Significance. DECT-derived perfusion showed superior reproducibility to 4DCT ventilation between timepoints 1 and 2, with consistently higher DSC and SSIM across thresholds. Despite systematic perfusion increases early in treatment, its spatial stability remained stronger, supporting DECT perfusion as a more robust biomarker for longitudinal lung function assessment and for informing adaptive, functionally-guided RT in NSCLC.
- Open Access
- 24 August 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (16) , 165025
Conventional and ultra-high dose rate proton beam energy and output characterization using a high-resolution multi-layer Faraday cup
Objective. Proton radiotherapy requires accurate quality assurance (QA) of beam range and output. Conventional QA methods using water phantoms and ionization chambers are time-consuming and may suffer from dose-rate dependence, limiting their use for FLASH radiation therapy at ultra-high dose rates (UHDRs). This work evaluated a multi-layer Faraday cup (MLFC) as a detector for proton therapy QA, capable of high-resolution energy verification, beam charge measurements, and operation at both conventional and UHDR. Approach. A commercial 128-layer MLFC made of thin copper layers separated by Kapton and equipped with a MicroHex TM energy filter was used to measure conventional and UHDR proton pencil beams from a IBA ProteusPlus system. A TOPAS Monte Carlo model was developed to benchmark depth-charge readout. Energy calibration of the pencil beams was performed by Gaussian fitting charge peaks and comparing to nominal ranges in water. Delivered charge was determined by integrating the collected charge across all MLFC channels and comparing it with a reference Faraday cup. Its application to UHDR FLASH radiotherapy was evaluated using spread-out Bragg Peak Conformal FLASH plan deliveries. Main results. The MLFC provided a reproducible high-resolution energy calibration within 1 mm water equivalent depth resolution, with the MicroHex TM filter broadening charge deposition peaks and improving measurement precision and accuracy. Integrated charge was linear with monitor units and agreed with Faraday cup measurements within 5% for all measured energies (100–228 MeV). The 4 kHz sampling rate enabled spot-by-spot energy and charge output measurements at UHDR. Significance. The MLFC enables simultaneous energy and charge output verification in a compact, dose-rate-independent detector, providing a practical solution for routine QA in both conventional and FLASH proton therapy.
- 24 August 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (16) , 165025
Open AccessConventional and ultra-high dose rate proton beam energy and output characterization using a high-resolution multi-layer Faraday cup
Objective. Proton radiotherapy requires accurate quality assurance (QA) of beam range and output. Conventional QA methods using water phantoms and ionization chambers are time-consuming and may suffer from dose-rate dependence, limiting their use for FLASH radiation therapy at ultra-high dose rates (UHDRs). This work evaluated a multi-layer Faraday cup (MLFC) as a detector for proton therapy QA, capable of high-resolution energy verification, beam charge measurements, and operation at both conventional and UHDR. Approach. A commercial 128-layer MLFC made of thin copper layers separated by Kapton and equipped with a MicroHex TM energy filter was used to measure conventional and UHDR proton pencil beams from a IBA ProteusPlus system. A TOPAS Monte Carlo model was developed to benchmark depth-charge readout. Energy calibration of the pencil beams was performed by Gaussian fitting charge peaks and comparing to nominal ranges in water. Delivered charge was determined by integrating the collected charge across all MLFC channels and comparing it with a reference Faraday cup. Its application to UHDR FLASH radiotherapy was evaluated using spread-out Bragg Peak Conformal FLASH plan deliveries. Main results. The MLFC provided a reproducible high-resolution energy calibration within 1 mm water equivalent depth resolution, with the MicroHex TM filter broadening charge deposition peaks and improving measurement precision and accuracy. Integrated charge was linear with monitor units and agreed with Faraday cup measurements within 5% for all measured energies (100–228 MeV). The 4 kHz sampling rate enabled spot-by-spot energy and charge output measurements at UHDR. Significance. The MLFC enables simultaneous energy and charge output verification in a compact, dose-rate-independent detector, providing a practical solution for routine QA in both conventional and FLASH proton therapy.
- Open Access
- 9 January 2026
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 37, 100378
Evaluating the dosimetric impact of intrafraction shifts on critical OAR doses for spine SBRT using an In-House simulator
- 9 January 2026
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 37, 100378
Open AccessEvaluating the dosimetric impact of intrafraction shifts on critical OAR doses for spine SBRT using an In-House simulator
- 29 July 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 70 (15) , 155006
Improving Cherenkov-based radiotherapy dose estimates in diverse patient populations via skin luminance imaging
Objective. Cherenkov imaging is an emerging technology that detects light naturally emitted from patient tissue during radiation treatment. The initial intensity of Cherenkov light is proportional to radiation dose, but its absorption is highly dependent on patient skin pigmentation, with increasing melanin attenuating more Cherenkov photons per dose. This effect must be calibrated per patient before Cherenkov emission can serve as an accurate surrogate for dose. In this study, we present the first attempt at in vivo Cherenkov imaging of a diverse patient cohort and calibration for the effect of skin pigmentation towards quantitative Cherenkov dosimetry. Approach. A multi-institutional collaboration was designed to increase the diversity of our patient imaging cohort. Cherenkov imaging was completed with a time-gated, iCMOS camera, and color background images were taken with an RGB camera module under standardized lighting. Under an institutional review board-approved retrospective protocol, skin pigmentation was assessed per patient by calculating the relative luminance of their treated area from the color images. Additionally, 2D dose maps were generated by projecting the exponentially-weighted dose from the surface to 5 mm into the body, representative of Cherenkov emission. Main results. Of N 6MV = 23 and N 15MV = 20 breast patients imaged, encompassing a variety of skin pigmentations, Cherenkov intensity varied nearly 5X for the same dose delivered across the examined cohort. Plotting Cherenkov intensity per unit dose revealed a direct correlation with relative luminance, providing a linear calibration factor based on skin pigmentation. Including this calibration factor significantly improved Cherenkov-to-dose linearity, from R 2 = 0.79–0.96 for 6 MV and R 2 = 0.19–0.91 for 15 MV (p < 0.05). Significance. This study marks the first assessment of Cherenkov imaging in a diverse, representative patient population. It addresses an integral factor towards achieving quantitative in vivo Cherenkov dosimetry and demonstrates significant mitigation of the effect of skin pigmentation, while preserving the non-contact, real-time benefits of Cherenkov imaging.
- 29 July 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 70 (15) , 155006
Improving Cherenkov-based radiotherapy dose estimates in diverse patient populations via skin luminance imaging
Objective. Cherenkov imaging is an emerging technology that detects light naturally emitted from patient tissue during radiation treatment. The initial intensity of Cherenkov light is proportional to radiation dose, but its absorption is highly dependent on patient skin pigmentation, with increasing melanin attenuating more Cherenkov photons per dose. This effect must be calibrated per patient before Cherenkov emission can serve as an accurate surrogate for dose. In this study, we present the first attempt at in vivo Cherenkov imaging of a diverse patient cohort and calibration for the effect of skin pigmentation towards quantitative Cherenkov dosimetry. Approach. A multi-institutional collaboration was designed to increase the diversity of our patient imaging cohort. Cherenkov imaging was completed with a time-gated, iCMOS camera, and color background images were taken with an RGB camera module under standardized lighting. Under an institutional review board-approved retrospective protocol, skin pigmentation was assessed per patient by calculating the relative luminance of their treated area from the color images. Additionally, 2D dose maps were generated by projecting the exponentially-weighted dose from the surface to 5 mm into the body, representative of Cherenkov emission. Main results. Of N 6MV = 23 and N 15MV = 20 breast patients imaged, encompassing a variety of skin pigmentations, Cherenkov intensity varied nearly 5X for the same dose delivered across the examined cohort. Plotting Cherenkov intensity per unit dose revealed a direct correlation with relative luminance, providing a linear calibration factor based on skin pigmentation. Including this calibration factor significantly improved Cherenkov-to-dose linearity, from R 2 = 0.79–0.96 for 6 MV and R 2 = 0.19–0.91 for 15 MV (p < 0.05). Significance. This study marks the first assessment of Cherenkov imaging in a diverse, representative patient population. It addresses an integral factor towards achieving quantitative in vivo Cherenkov dosimetry and demonstrates significant mitigation of the effect of skin pigmentation, while preserving the non-contact, real-time benefits of Cherenkov imaging.
- 20 March 2025
- Published by SPIE-Intl Soc Optical Eng in Proceedings of SPIE
- Vol. 13309, 14-50
Real-time dosimetry using scintillator technology in external beam radiation therapy (EBRT)
Total Skin Electron Therapy (TSET) is a specialized radiotherapy technique used for the treatment of cutaneous T-cell lymphoma and other diffuse skin malignancies. Accurate real-time dosimetry is essential for ensuring precise dose delivery while minimizing toxicity to healthy tissues. This study presents the development and implementation of an advanced scintillator-based real-time dosimetry system designed to enhance dosimetry precision in TSET, utilizing a source-tosurface distance (SSD) of 5 meters with an intervening spoiler to optimize dose distribution. In a phantom study, nine scintillators were vertically positioned 20 cm apart on a white PVC board, alongside diodes that served as absolute dose references. Scintillator signals were captured using Cherenkov imaging cameras and fitting with correction factors were applied to ensure consistency between scintillator and diode-based dose measurements. Additionally, in vivo patient data were analyzed, revealing variations in scintillator response depending on positioning and camera selection. The results indicate that scintillators provide a feasible solution for real-time dosimetry in TSET, contingent upon strict regulation of scintillator placement and patient posture. Further optimization and standardization of scintillator positioning are necessary to enhance clinical implementation and dosimetry accuracy, ensuring reliable and precise dose monitoring in TSET applications.
- 20 March 2025
- Published by SPIE-Intl Soc Optical Eng in Proceedings of SPIE
- Vol. 13309, 14-50
Real-time dosimetry using scintillator technology in external beam radiation therapy (EBRT)
Total Skin Electron Therapy (TSET) is a specialized radiotherapy technique used for the treatment of cutaneous T-cell lymphoma and other diffuse skin malignancies. Accurate real-time dosimetry is essential for ensuring precise dose delivery while minimizing toxicity to healthy tissues. This study presents the development and implementation of an advanced scintillator-based real-time dosimetry system designed to enhance dosimetry precision in TSET, utilizing a source-tosurface distance (SSD) of 5 meters with an intervening spoiler to optimize dose distribution. In a phantom study, nine scintillators were vertically positioned 20 cm apart on a white PVC board, alongside diodes that served as absolute dose references. Scintillator signals were captured using Cherenkov imaging cameras and fitting with correction factors were applied to ensure consistency between scintillator and diode-based dose measurements. Additionally, in vivo patient data were analyzed, revealing variations in scintillator response depending on positioning and camera selection. The results indicate that scintillators provide a feasible solution for real-time dosimetry in TSET, contingent upon strict regulation of scintillator placement and patient posture. Further optimization and standardization of scintillator positioning are necessary to enhance clinical implementation and dosimetry accuracy, ensuring reliable and precise dose monitoring in TSET applications.
- 20 March 2025
- Published by SPIE-Intl Soc Optical Eng in Proceedings of SPIE
- Vol. 13309, 39-44
Understanding the impact of patient-specific geometries on Cherenkov emission-to-dose relationship during external beam radiation therapy (EBRT)
Cherenkov photons generated during External Beam Radiation Therapy (EBRT) provide real-time optical feedback on the radiation field distribution. While Cherenkov emission correlates with radiation dose, patient-specific anatomical variations, particularly breast geometry, introduce inconsistencies in the Cherenkov emission-to-dose ratio. This study investigates the influence of breast contour, specifically curvature, on the accuracy of Cherenkov-based dosimetry. To address these variations, patient-specific Cherenkov imaging data is corrected using Lambertian geometric correction and compared with the planned radiation dose to derive a correction function as a function of breast curvature. Additionally, scintillator-based Cherenkov imaging data is analyzed and compared with in vivo dosimetry to assess the feasibility of scintillators as real-time dosimeters for EBRT.
- 20 March 2025
- Published by SPIE-Intl Soc Optical Eng in Proceedings of SPIE
- Vol. 13309, 39-44
Understanding the impact of patient-specific geometries on Cherenkov emission-to-dose relationship during external beam radiation therapy (EBRT)
Cherenkov photons generated during External Beam Radiation Therapy (EBRT) provide real-time optical feedback on the radiation field distribution. While Cherenkov emission correlates with radiation dose, patient-specific anatomical variations, particularly breast geometry, introduce inconsistencies in the Cherenkov emission-to-dose ratio. This study investigates the influence of breast contour, specifically curvature, on the accuracy of Cherenkov-based dosimetry. To address these variations, patient-specific Cherenkov imaging data is corrected using Lambertian geometric correction and compared with the planned radiation dose to derive a correction function as a function of breast curvature. Additionally, scintillator-based Cherenkov imaging data is analyzed and compared with in vivo dosimetry to assess the feasibility of scintillators as real-time dosimeters for EBRT.
- 13 March 2024
- Published by SPIE-Intl Soc Optical Eng
- Vol. 12834, 33-51
Improving Cherenkov-to-dose linearity in tissue for quantitative surface dosimetry during whole breast radiation therapy
Imaging Cherenkov photons emitted during radiation therapy can provide real-time information of the external beam field. It is well established that Cherenkov emission is correlative to dose deposited; however, differential photon energies and tissue attenuation properties, along with complicated camera geometries, entangle this relationship and introduce variability in the Cherenkov emission-to-dose ratio from patient-to-patient. This study aims to better understand the effects of optical properties, skin color, and patient-specific geometries (i.e. angle of camera incidence and curvature) on the Cherenkov emission-to-dose relationship. To do so, a series of phantom experiments were conducted with tissuesimulating optical phantoms and an andromorphic breast phantom in which optical properties, curvature, and camera angle of incidence were all examined as a function of normalized Cherenkov emission-to-dose. To acquire clinical Cherenkov data along with patient skin color, Cherenkov images and OSLD measurements for the ground-truth surface dose were collected weekly on 13 whole-breast radiotherapy patients, alongside high-resolution 3D color and texture scans. Phantom results suggest there to be a moderately strong correlation between dose percent error and patient curvature (R2 = 0.57), as well as angle of camera incidence (R2 = 0.56). Initial patient results suggest there to be a correlation between the redness of a patient’s skin, and the Cherenkov emission-to-dose ratio, with higher amounts of redness correlating to lower Cherenkov signal. By better characterizing these trends, we are potentially able to find generalizable optics-based corrections that improve the accuracy in mapping Cherenkov emission to real-time skin dose.
- 13 March 2024
- Published by SPIE-Intl Soc Optical Eng
- Vol. 12834, 33-51
Improving Cherenkov-to-dose linearity in tissue for quantitative surface dosimetry during whole breast radiation therapy
Imaging Cherenkov photons emitted during radiation therapy can provide real-time information of the external beam field. It is well established that Cherenkov emission is correlative to dose deposited; however, differential photon energies and tissue attenuation properties, along with complicated camera geometries, entangle this relationship and introduce variability in the Cherenkov emission-to-dose ratio from patient-to-patient. This study aims to better understand the effects of optical properties, skin color, and patient-specific geometries (i.e. angle of camera incidence and curvature) on the Cherenkov emission-to-dose relationship. To do so, a series of phantom experiments were conducted with tissuesimulating optical phantoms and an andromorphic breast phantom in which optical properties, curvature, and camera angle of incidence were all examined as a function of normalized Cherenkov emission-to-dose. To acquire clinical Cherenkov data along with patient skin color, Cherenkov images and OSLD measurements for the ground-truth surface dose were collected weekly on 13 whole-breast radiotherapy patients, alongside high-resolution 3D color and texture scans. Phantom results suggest there to be a moderately strong correlation between dose percent error and patient curvature (R2 = 0.57), as well as angle of camera incidence (R2 = 0.56). Initial patient results suggest there to be a correlation between the redness of a patient’s skin, and the Cherenkov emission-to-dose ratio, with higher amounts of redness correlating to lower Cherenkov signal. By better characterizing these trends, we are potentially able to find generalizable optics-based corrections that improve the accuracy in mapping Cherenkov emission to real-time skin dose.
- 13 October 2023
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 68 (20) , 20NT02
Characterization of Cherenkov imaging parameters and positional constraints on an O-ring linear accelerator
Objective. With the introduction of Cherenkov imaging technology on the Halcyon O-ring linear accelerator platform, we seek to demonstrate the imaging feasibility and optimize camera placement. Approach. Imaging parameters were probed by acquiring triggering data Cherenkov image frames for simplistic beams on the Halcyon and comparing the analyzed metrics with those from the TrueBeam platform. Camera position was analyzed by performing 3D rendering of patient treatment plans for various sites and iterating over camera positions to assess treatment area visibility. Main results. Commercial Cherenkov imaging systems are compatible with the pulse timing of the Halcyon, and this platform design favorably impacts signal to noise in Cherenkov image frames. Additionally, ideal camera placement is treatment site dependent and is always within a biconical zone of visibility centered on the isocenter. Visibility data is provided for four treatment sites, with suggestions for camera placement based on room dimensions. Median visibility values were highest for right breast plans, with values of 80.33% and 68.49% for the front and rear views respectively. Head and neck plans presented with the lowest values at 26.44% and 38.18% respectively. Significance. This work presents the first formal camera positional analysis for Cherenkov imaging on any platform and serves as a template for performing similar work for other irradiation platforms. Additionally, this study confirms the Cherenkov imaging parameters do not need to be changed for optimal imaging on the Halcyon. Lastly, the presented methodology provides a framework which could be further expanded to other optical imaging systems which rely on line of sight visibility to the patient.
- 13 October 2023
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 68 (20) , 20NT02
Characterization of Cherenkov imaging parameters and positional constraints on an O-ring linear accelerator
Objective. With the introduction of Cherenkov imaging technology on the Halcyon O-ring linear accelerator platform, we seek to demonstrate the imaging feasibility and optimize camera placement. Approach. Imaging parameters were probed by acquiring triggering data Cherenkov image frames for simplistic beams on the Halcyon and comparing the analyzed metrics with those from the TrueBeam platform. Camera position was analyzed by performing 3D rendering of patient treatment plans for various sites and iterating over camera positions to assess treatment area visibility. Main results. Commercial Cherenkov imaging systems are compatible with the pulse timing of the Halcyon, and this platform design favorably impacts signal to noise in Cherenkov image frames. Additionally, ideal camera placement is treatment site dependent and is always within a biconical zone of visibility centered on the isocenter. Visibility data is provided for four treatment sites, with suggestions for camera placement based on room dimensions. Median visibility values were highest for right breast plans, with values of 80.33% and 68.49% for the front and rear views respectively. Head and neck plans presented with the lowest values at 26.44% and 38.18% respectively. Significance. This work presents the first formal camera positional analysis for Cherenkov imaging on any platform and serves as a template for performing similar work for other irradiation platforms. Additionally, this study confirms the Cherenkov imaging parameters do not need to be changed for optimal imaging on the Halcyon. Lastly, the presented methodology provides a framework which could be further expanded to other optical imaging systems which rely on line of sight visibility to the patient.
- 14 March 2023
- Published by SPIE-Intl Soc Optical Eng in Proceedings of SPIE
- Vol. 12359, 39-46
Evaluation of the cumulative Cherenkov converted dose on TSET patients with multiple Cherenkov cameras
Cherenkov images can be used for the quality assurance of dose homogeneity in total skin electron therapy (TSET). For the dose mapping purpose, this study reconstructed the patient model from 3D scans using registration algorithms and computer animation techniques. The Cherenkov light emission of the patient’s surface was extracted from multi-view Cherenkov images, converted into dose distribution, and projected onto the patient’s 3D model, allowing for dose cumulation and evaluation. The projected result from multiple Cherenkov cameras provides additional information about Cherenkov emission on the sides of the patients, which improves the agreement between the Cherenkov converted dose and the OSLD measurements.
- 14 March 2023
- Published by SPIE-Intl Soc Optical Eng in Proceedings of SPIE
- Vol. 12359, 39-46
Evaluation of the cumulative Cherenkov converted dose on TSET patients with multiple Cherenkov cameras
Cherenkov images can be used for the quality assurance of dose homogeneity in total skin electron therapy (TSET). For the dose mapping purpose, this study reconstructed the patient model from 3D scans using registration algorithms and computer animation techniques. The Cherenkov light emission of the patient’s surface was extracted from multi-view Cherenkov images, converted into dose distribution, and projected onto the patient’s 3D model, allowing for dose cumulation and evaluation. The projected result from multiple Cherenkov cameras provides additional information about Cherenkov emission on the sides of the patients, which improves the agreement between the Cherenkov converted dose and the OSLD measurements.
- 6 March 2023
- Published by SPIE-Intl Soc Optical Eng in Proceedings of SPIE
- Vol. 12371, 23-34
Comparison of surface dose during whole breast radiation therapy on Halcyon and TrueBeam using Cherenkov imaging
The emergence of the Halcyon linear accelerator has allowed for increased patient throughput and improved treatment times for common treatment sites in radiation oncology. However, it has been shown that this can lead to increased surface dose in sites like breast cancer compared with treatments on conventional machines with flattened radiation beams. Cherenkov imaging can be used to estimate surface dose by detection of Cherenkov photons emitted in proportion to energy deposition from high energy electrons in tissue. Phantom studies were performed with both square beams in reference conditions and with clinical treatments, and dosimeter readings and Cherenkov images report higher surface dose (25% for flat phantom entrance dose, 5.9% for breast phantom treatment) from Halcyon beam deliveries than for equivalent deliveries from a TrueBeam linac. Additionally, the first Cherenkov images of a patient treated with Halcyon were acquired, and superficial dose was estimated.
- 6 March 2023
- Published by SPIE-Intl Soc Optical Eng in Proceedings of SPIE
- Vol. 12371, 23-34
Comparison of surface dose during whole breast radiation therapy on Halcyon and TrueBeam using Cherenkov imaging
The emergence of the Halcyon linear accelerator has allowed for increased patient throughput and improved treatment times for common treatment sites in radiation oncology. However, it has been shown that this can lead to increased surface dose in sites like breast cancer compared with treatments on conventional machines with flattened radiation beams. Cherenkov imaging can be used to estimate surface dose by detection of Cherenkov photons emitted in proportion to energy deposition from high energy electrons in tissue. Phantom studies were performed with both square beams in reference conditions and with clinical treatments, and dosimeter readings and Cherenkov images report higher surface dose (25% for flat phantom entrance dose, 5.9% for breast phantom treatment) from Halcyon beam deliveries than for equivalent deliveries from a TrueBeam linac. Additionally, the first Cherenkov images of a patient treated with Halcyon were acquired, and superficial dose was estimated.